by Andrea Palladino | Aug 24, 2023 | Uncategorized
Takeda decidió voluntariamente sustituir los dispositivos de reconstitución BAXJECT II y BAXJECT II Hi-Flow producidos por el fabricante de dispositivos contratado por Takeda entre octubre de 2021 y enero de 2022. Esta es una medida precautoria debida a la posible...
by Andrea Palladino | Aug 21, 2023 | Uncategorized
[Update from the National Bleeding Disorders Foundation] Takeda has brought to our attention an issue with some BAXJECT® II reconstitution devices produced between October 2021 and January 2022 for use in conjunction with RECOMBINATE [Antihemophilic Factor...
Recent Comments